Multiple current and laid-off FDA employees said the abrupt layoffs had resulted in delays and disruptions to the agency's ...

The U.S. Food and Drug Administration will meet its targets for completing reviews of new drugs despite mass firings at the ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

The FDA doesn’t plan to execute a reorganization of the agency but will consolidate offices that handle travel, technology, ...

The U.S. Food and Drug Administration has delayed its decision on marketing approval for Stealth BioTherapeutics' treatment ...

Cutting staff is quick way to lower your costs, but a haphazard approach like DOGE's could cost your company if you ...

Food and drink companies will have to stop using petroleum-based dyes by the end of 2026, Health and Human Services officials ...

US FDA grants breakthrough device designation to Roche’s companion diagnostic, VENTANA TROP2 (EPR20043) RxDx Device for non-small cell lung cancer: Basel Wednesday, April 30, 20 ...

Just before the change in administration, the Food and Drug Administration (FDA) made headlines by revoking approvals to use the color additive ...

Recently, the FDA announced the removal of certain compounded GLP1 ingredients from its drug shortage list. These ingredients ...

The Food and Drug Administration (“FDA”) has removed semaglutide from its drug shortage list after the agency determined the current supply of ...

The FDA's ban on petroleum-based food dyes raises questions about other ingredients. Explore the implications and future of ...